Mutation in IDH1 mostly affects Arg132 codon (R132), which is the binding site for isocitrate, and R132H is the most common alteration, comprising greater than 80% of all IDH1 mutations in gliomas [70]. The gene discussed is IDH1; the disease is central nervous system cancer.